Warthin-like variant of papillary thyroid carcinoma (WLV-PTC) was first described by Apel *et al*. \[[@b1-jptm-2017-12-26]\] in 1995 and named "warthin-like" due to the presence of abundant lymphocytes interspersed in oncocytic follicular epithelial cells resembling the warthin tumor of salivary glands. It is a relatively rare variant of papillary thyroid carcinoma with only 95 cases published in the English literature \[[@b2-jptm-2017-12-26]\]. This tumor expresses the product of the *RET/PTC* fusion gene, indicating that it is a variant of papillary thyroid carcinoma \[[@b3-jptm-2017-12-26]\]. WLV-PTC is a favorable prognostic variant \[[@b1-jptm-2017-12-26],[@b3-jptm-2017-12-26],[@b4-jptm-2017-12-26]\] although ominous behavior has also been reported \[[@b5-jptm-2017-12-26]\]. The diagnosis of WLV-PTC is relatively simple due to its characteristic morphology. However, preoperative diagnosis using fine-needle aspiration (FNA) samples is challenging because abundant lymphocytes and oncocytic follicular epithelial cells (Hürthle cells) are observed in various lesions associated with lymphocytic thyroiditis. In this study, we compared FNA findings of WLV-PTC, conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT), and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC). The characteristics of infiltrating inflammatory cells and their distribution were analyzed to evaluate their usefulness for differential diagnosis. Preoperative differential diagnosis of WLV-PTC will be helpful for surgeons to determine the optimal scope of operation.

MATERIALS AND METHODS
=====================

Patients and cases
------------------

We retrieved 8,179 papillary thyroid carcinoma cases from the Thyroid Cancer Center database, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea between January 2007 and December 2012. Based on the final pathological diagnosis, 16 patients (0.2%) were WLV-PTC including outside consultation cases. We were able to reexamine cytology slides from four of the patients. Six PTC-LT cases and five PTC cases were randomly selected for comparison ([Table 1](#t1-jptm-2017-12-26){ref-type="table"}). Each case had been prepared for both conventional smear and liquid-based cytology (ThinPrep, Hologic, Bedford, MA, USA). The Institutional Review Board of Gangnam Severance Hospital (local IRB number: 3-2017-0235) approved this retrospective study and informed consent was waived.

Microscopic evaluation
----------------------

Three slides (two conventional smears and one ThinPrep) were reviewed in each case. The number of background lymphocytes within tumor clusters as well as the number of histiocytes and neutrophils was counted in 10 high power fields (HPFs, × 200) in each sample slide. Tumor clusters composed of at least five tumor cells were included in this counting. The presence or absence of background giant cells was recorded. In each case, the average number of inflammatory cells per one HPF was recorded and separated into low and high groups for comparison. The cut-off points are shown in [Tables 2](#t2-jptm-2017-12-26){ref-type="table"} and [3](#t3-jptm-2017-12-26){ref-type="table"}.

Statistical analysis
--------------------

The median number of inflammatory cells per one HPF was compared using the Mann-Whitney U test. Binary group distribution regarding inflammatory cell infiltration was compared using the Fisher\'s exact test. All statistical analyses were performed using SPSS ver. 23.0 (IBM Corp, Armonk, NY, USA) and p-values less than 0.05 were considered statistically significant.

RESULTS
=======

The baseline clinicopathologic characteristics of each case such as age, gender, preoperative sonographic finding, preoperative FNA diagnosis, surgical pathologic diagnosis, tumor size, and associated thyroiditis are shown in [Table 1](#t1-jptm-2017-12-26){ref-type="table"}. The WLV-PTC, PTC-LT, and PTC microscopic findings are shown in [Fig. 1](#f1-jptm-2017-12-26){ref-type="fig"}. Conventional smear and ThinPrep WLV-PTC samples showed irregular and papillary clusters with oncocytic cytoplasm and many lymphocytes within the tumor clusters and background ([Fig. 1B](#f1-jptm-2017-12-26){ref-type="fig"}--[E](#f1-jptm-2017-12-26){ref-type="fig"}) contrary to those of PTC-LT ([Fig. 1G](#f1-jptm-2017-12-26){ref-type="fig"}--[J](#f1-jptm-2017-12-26){ref-type="fig"}) and PTC ([Fig. 1L](#f1-jptm-2017-12-26){ref-type="fig"}--[O](#f1-jptm-2017-12-26){ref-type="fig"}) showing rare intratumoral and background lymphocytes. In WLV-PTC, the lymphocytic smear pattern was not different between the conventional and ThinPrep preparations.

The median number, range, and group distributions of inflammatory cells in WLV-PTC, PTC-LT, and PTC in conventional smears and in liquid-based smears are summarized in [Tables 2](#t2-jptm-2017-12-26){ref-type="table"} and [3](#t3-jptm-2017-12-26){ref-type="table"}. In conventional smears, WLV-PTC showed a tendency for association with higher numbers of lymphocytes within tumor clusters and in the background compared with PTC-LT or PTC. WLV-PTC was significantly associated with a high number of background lymphocytes compared with PTC (p = .048). In ThinPrep preparations, WLV-PTC also showed a significantly higher median number of lymphocytes within tumor clusters (p = .008), in the background (p = .008), and was significantly associated with higher lymphocytes within tumor clusters (p = .008) and the background (p = .008) compared with PTC. WLV-PTC showed a tendency for association with higher lymphocytes within tumors, in the background, and with higher histiocytes. WLV-PTC showed a significantly higher median number of histiocytes per one HPF (p = .048).

As an incidental finding, PTC-LT showed a neutrophilic smear with a higher median number compared with WLV-PTC or PTC ([Tables 2](#t2-jptm-2017-12-26){ref-type="table"}, 3, [Fig. 1](#f1-jptm-2017-12-26){ref-type="fig"}G--J); however, the result was not statistically significant.

DISCUSSION
==========

WLV-PTC is a rare variant of PTC having characteristic histologic features; therefore, histologic diagnosis of this tumor is usually straightforward. However, preoperative diagnosis using conventional or liquid-based cytology techniques is complicated because several diseases resemble each other based on cytologic features. The first description of WLV-PTC cytologic features was done by Yousef *et al*. in 1997 \[[@b6-jptm-2017-12-26]\]. Since then, nuclear features typical of PTC combined with oncocytic cytoplasm and lymphocytic background were considered to be the cytologic features of WLV-PTC. Therefore, every tumor or tumor-like condition having both nuclear pseudoinclusions in follicular cells and lymphocytic background should be included on the list of differential diagnoses. This list includes Hashimoto's thyroiditis, follicular neoplasm with oncocytic change, oncocytic variant of PTC \[[@b7-jptm-2017-12-26]\], PTC in the background of Hashimoto's thyroiditis, and tall cell variant of PTC \[[@b8-jptm-2017-12-26]\]. Paker *et al*. \[[@b8-jptm-2017-12-26]\] said the most important differential point is mixture of lymphocytes and oncocytic follicular cells, tissue fragments, and papillary structures. However, distinguishing these diseases by cytologic examination is not always clear cut. Especially in liquid-based cytology, cell clusters are easily dissolved during preparation, which can confer further diagnostic difficulty \[[@b7-jptm-2017-12-26]\].

In this study, we selected WLV-PTC, PTC-LT, and conventional PTC cases of which the diagnosis was confirmed by postoperative pathological examination. We compared preoperative cytology slides and investigated whether specific clues other than nuclear feature and lymphocytic background could distinguish these diseases. We focused on the component and amount of background and intratumoral inflammatory cells.

Although limitations of our study include relatively small WLV-PTC sample size due to the rarity of the disease, WLV-PTC was associated with higher lymphocytes and histiocytes within tumor clusters and within the background as well. The difference was more distinct in ThinPrep preparations.

Our investigation implies that analyzing inflammatory components in preoperative cytologic diagnosis could be helpful in the differential diagnosis between WLV-PTC and conventional PTC without lymphocytic thyroiditis. If lymphocytes within tumor clusters are also considered, the preoperative diagnosis of this rare WLV-PTC variant is possible; however, further multiinstitutional studies including a large number of WLV-PTC cases will be needed.
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![Microscopic findings of Warthin-like variant of papillary thyroid carcinoma (WLV-PTC), conventional papillary thyroid carcinoma with lymphocytic thyroiditis (PTC-LT), and conventional papillary thyroid carcinoma without lymphocytic thyroiditis (PTC). (A) Histologic findings of WLV-PTC. WLV-PTC is composed of atypical follicular cells with abundant oxyphilic cytoplasm and nuclear grooves (inset) showing papillary structures with abundant lymphoid stroma. (B, C) Conventional smear of WLV-PTC showing irregular papillary clusters and numerous lymphocytes in tumor clusters in the bloody background. (D, E) Inflammatory and multinucleated giant cells are rather evenly distributed and hypercellular relative to the conventional smear. Intratumoral lymphocytes are easily seen. (F) Histologic findings of PTC-LT. (G, H) Conventional PTC-LT smear showing papillary tumor clusters without intratumoral lymphocytes, but some neutrophils seen around the tumor clusters in the lymphocytic background. (I, J) Peritumoral neutrophils seen in the lymphocytic background. (K) Histologic findings of PTC. (L--O) Hypercellular smear showing classic cytologic features of papillary carcinoma without inflammatory cells in background in both the conventional smear (L, M) and in ThinPrep (N, O) preparations.](jptm-2017-12-26f1){#f1-jptm-2017-12-26}

###### 

Baseline clinicopathologic characteristics of each case

  Case No.   Age (yr)/Sex   Tumor size (cm)   Sonographic feature                      FNA diagnosis^[a](#tfn1-jptm-2017-12-26){ref-type="table-fn"}^   Pathologic diagnosis   Associated thyroiditis
  ---------- -------------- ----------------- ---------------------------------------- ---------------------------------------------------------------- ---------------------- ------------------------
  1          46/F           1.0               Irregular shaped calcified nodule        VI\. PTC                                                         PTC-LT                 Present
  2          45/F           0.9               Suspicious malignant nodule              VI\. PTC                                                         PTC-LT                 Present
  3          46/F           0.6               Suspicious malignant nodule              V. Suspicious PTC                                                PTC-LT                 Present
  4          53/F           0.4               Suspicious lesion                        VI\. PTC                                                         PTC-LT                 Present
  5          53/F           0.6               Suspicious nodule                        V. Suspicious PTC                                                PTC-LT                 Present
  6          62/F           0.4               Taller than wider hypoechoic nodule      VI\. PTC                                                         PTC-LT                 Present
  7          76/F           0.5               Suspicious nodule                        VI\. PTC                                                         PTC                    Absent
  8          44/F           0.7               Suspicious malignant nodule              V. Suspicious PTC                                                PTC                    Absent
  9          49/F           0.6               Suspicious lesion                        VI\. PTC                                                         PTC                    Absent
  10         70/M           1.0               Cancer nodule                            VI\. PTC                                                         PTC                    Absent
  11         57/F           0.3               Suspicious lesion                        VI\. PTC                                                         PTC                    Absent
  12         33/F           1.4               Suspicious nodule                        VI\. PTC                                                         WLV-PTC                Present
  13         59/F           0.3               Low suspicious nodule                    V. Suspicious PTC                                                WLV-PTC                Absent
  14         40/F           0.6               Oval shaped mass with poor enhancement   V. Suspicious PTC                                                WLV-PTC                Absent
  15         48/F           0.4               Suspicious nodule                        VI\. PTC                                                         WLV-PTC                Present

FNA, fine-needle aspiration; F, female; PTC, conventional papillary thyroid carcinoma without lymphocytic thyroiditis around the tumor; PTC-LT, conventional papillary thyroid carcinoma with lymphocytic thyroiditis around the tumor; M, male; WLV-PTC, Warthin-like variant of papillary thyroid carcinoma.

Diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.

###### 

Comparison of inflammatory cell components among the papillary thyroid cancer groups in conventional smears

  Inflammatory cell component   WLV-PTC (n = 4)   PTC-LT (n = 6)   PTC (n = 5)     WLV-PTC vs PTC-LT p-value                               WLV-PTC vs PTC p-value
  ----------------------------- ----------------- ---------------- --------------- ------------------------------------------------------- -------------------------------------------------------
  Lymphocyte                                                                                                                               
   Background                   38.00 (1--154)    7.50 (1--41)     14.00 (5--22)   .524^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^   .206^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^
    Low (≤ 30)                  1 (25)            5 (83)           5 (100)         .190^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^   .048^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^
    High (\> 30)                3 (75)            1 (17)           0                                                                       
   Within tumor                 11.50 (0--51)     1.50 (0--3)      0.00 (0--2)     .999^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^   .524^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^
    Low (≤ 10)                  2 (50)            6 (100)          5 (100)         .133^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^   .167^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^
    High (\> 10)                2 (50)            0                0                                                                       
  Histiocyte                    5.00 (1--9)       1.00 (0--2)      1.00 (1--29)    .999^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^   .999^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^
   Low (\< 1)                   1 (25)            2 (33)           0               .999^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^   .444^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^
   High (≥ 1)                   3 (75)            4 (67)           5 (100)                                                                 
  Giant cell                                                                                                                               
   Absent                       2 (50)            3 (50)           3 (60)          .999^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^   .999^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^
   Present                      2 (50)            3 (50)           2 (40)                                                                  
  Neutrophil                    3.50 (0--6)       5.00 (1--22)     4.00 (1--26)    .999^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^   .999^[a](#tfn2-jptm-2017-12-26){ref-type="table-fn"}^
   Low (≤ 10)                   4 (100)           4 (67)           4 (80)          .467^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^   .999^[b](#tfn3-jptm-2017-12-26){ref-type="table-fn"}^
   High (\> 10)                 0                 2 (33)           1 (20)                                                                  

Values are presented as median (range) or number (%).

WLV-PTC, Warthin-like variant of papillary thyroid carcinoma; PTC-LT, conventional papillary thyroid carcinoma with lymphocytic thyroiditis around the tumor; PTC, conventional papillary thyroid carcinoma without lymphocytic thyroiditis around the tumor.

Mann--Whitney U test;

Fisher exact test.

###### 

Comparison of inflammatory cell components among the papillary thyroid cancer groups in liquid-based cytology (ThinPrep)

                   WLV-PTC (n = 4)   PTC-LT (n = 6)   PTC (n = 5)    WLV-PTC vs PTC-LT p-value                               WLV-PTC vs PTC p-value
  ---------------- ----------------- ---------------- -------------- ------------------------------------------------------- -------------------------------------------------------
  Lymphocyte                                                                                                                 
   Background      38.00 (17--47)    23.50 (6--71)    4.00 (2--8)    .999^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^   .008^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^
    Low (≤ 10)     0                 3 (50)           5 (100)        .200^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^   .008^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^
    High (\> 10)   4 (100)           3 (50)           0                                                                      
   Within tumor    14.50 (5--22)     3.50 (0--10)     0 (0--0)       .190^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^   .008^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^
    Low (\< 1)     0 (0)             2 (33)           5 (100)        .467^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^   .008^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^
    High (≥ 1)     4 (100)           4 (66)           0                                                                      
  Histiocyte       11.00 (8--12)     1.50 (0--13)     1.00 (0--91)   .048^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^   .206^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^
   Low (≤ 10)      1 (25)            5 (83)           4 (80)         .190^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^   .206^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^
   High (\> 10)    3 (75)            1 (17)           1 (20)                                                                 
  Giant cell                                                         .400^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^   .524^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^
   Absent          1 (25)            0                3 (60)                                                                 
   Present         3 (75)            6 (100)          2 (40)                                                                 
  Neutrophil       3.00 (1--12)      16.00 (1--47)    2.00 (0--10)   .524^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^   .999^[a](#tfn4-jptm-2017-12-26){ref-type="table-fn"}^
   Low (≤ 10)      3 (75)            3 (50)           5 (100)        .571^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^   .444^[b](#tfn5-jptm-2017-12-26){ref-type="table-fn"}^
   High (\> 10)    1 (25)            3 (50)           0                                                                      

Values are presented as median (range) or number (%).

WLV-PTC, Warthin-like variant of papillary thyroid carcinoma; PTC-LT, conventional papillary thyroid carcinoma with lymphocytic thyroiditis around the tumor; PTC, conventional papillary thyroid carcinoma without lymphocytic thyroiditis around the tumor.

Mann--Whitney U test;

Fisher exact test.
